Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biomea Fusion, Inc. - Common Stock (NQ:BMEA)

1.450 -0.070 (-4.61%)
Streaming Delayed Price Updated: 10:50 AM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Biomea Fusion, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Biomea Fusion's Stock Plummets After Price Target Cut — Bearish Retail Traders Speculate Next Moves
Biomea Fusion is realigning its focus on diabetes and obesity programs, cutting 35% of its workforce and consolidating operations to reduce costs. 
Via Stocktwits
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Is Diabetes-Drug Developer Biomea Fusion Stock Trading Lower On Tuesday?
Biomea Fusion's COVALENT-111 study shows icovamenib reduces HbA1c significantly in T2D patients, with no safety concerns or drug interactions. 
Via Benzinga
Arcadium Lithium, Norwegian Cruise Line, GitLab, Chewy And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
FDA Removes Clinical Hold On Biomea Fusion's Early-Stage Trials For Potential Diabetes Candidate
FDA has lifted the clinical hold on Biomea Fusion's BMF-219 trials for type 1 and type 2 diabetes following a safety review, allowing the ongoing studies to resume. 
Via Benzinga
Exposures Product Safety
Nasdaq Moves Lower; Fed's Preferred Inflation Gauge Falls More Than Projected
Via Benzinga
Topics Economy
Exposures Interest Rates
IonQ, Biomea Fusion, Rocket Lab USA And Other Big Stocks Moving Higher On Friday
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
BMEA Stock Earnings: Biomea Fusion Beats EPS for Q2 2024
BMEA stock results show that Biomea Fusion beat analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
This Cleveland-Cliffs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
Crude Oil Edges Lower; Asensus Surgical Shares Jump
Via Benzinga
Exposures Fossil Fuels
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Gold Falls Sharply; Geron Shares Spike Higher
Via Benzinga
Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Biomea Fusion (BMEA) Stock Is Down 60%
Biomea Fusion shares are trading lower by 62.7% during Friday's session. The company received notice from the FDA that Its trials of BMF-219 have been placed on clinical hold. 
Via Benzinga
Exposures Product Safety
US Stocks Lower; Nonfarm Payrolls Increase More Than Expected
Via Benzinga
Biomea Fusion Crashes 65% After FDA Puts Diabetes Treatment Studies On Hold
The FDA cited concerns of liver toxicity, but the company says its drug has been generally well-tolerated. 
Via Investor's Business Daily
Exposures Product Safety
Why Is Virax Biolabs (VRAX) Stock Down 15% Today?
Virax Biolabs stock is down on Friday as shares of VRAX come off of a massive rally yesterday that didn't come with any news. 
Via InvestorPlace
Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Why Is Biomea Fusion (BMEA) Stock Down 63% Today?
Biomea Fusion stock is falling on Friday after investors learned of the FDA placing a clinical hold on its Phase I/II clinical trials. 
Via InvestorPlace
Exposures Product Safety
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Pre-market stock movers are worth checking out on Friday as we dig into all of the biggest news affecting shares this morning! 
Via InvestorPlace
This Pharma Stock Dropped 60% Premarket As FDA Halted Diabetes Drug Trials
Elevated liver enzyme levels were noted, although most adverse events were mild to moderate, with no severe reactions reported. 
Via Benzinga
Exposures Product Safety
Ride the Gamma Wave: 3 Stocks on the Verge of a Short Squeeze
Though short squeezes are never guaranteed, these three potential short squeeze stocks could provide generous returns if bought right. 
Via InvestorPlace
Why Braze Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.